eClinical Solutions’ Post

🌐 Pharma Investment Mastery: Navigate Challenges with Trillioni Pharma! Calling all pharma investors and distributors! Ever felt the hurdles in this industry? Let's dive in and discover how Trillioni Pharma revolutionizes the game: Challenges: -Market Complexity: Pharma is vast, making it tricky to spot the right opportunities. -Rules and Regulations: Dealing with regulations is a puzzle; we know it's a challenge. -Global Ties: Connecting worldwide? It's not easy, but it's essential. Risk Understanding: Assessing investment risks needs a keen eye. How Trillioni Pharma Helps: All-in-One Platform: We bring investors, distributors, and manufacturers together. -Regulation Know-How: Our team's got the scoop on regulations, so you can focus on your goals. -Global Network: Connect globally with trusted manufacturers and distributors. -Smart Insights: Our data-driven insights make decision-making a breeze. Ready to tackle these challenges? Join Trillioni Pharma and transform your pharma investments. 🚀 #PharmaInvestor #innovationhub 🚀 #pharma #pharmaceuticals #healthcare #medicine #biotech #lifesciences #innovation #medtech #biopharma #healthtech #drugdevelopment

In FY23, the overall Indian healthcare market was around $180 billion with healthcare innovation accounting for $30 billion, or 15% of the market. While the healthcare innovation market is largely dominated by pharma services and health tech, biotech, and medtech are also some of the emerging areas that show promise. Read more here -https://bit.ly/4ejFQLQ #Healthcare #HealthcareInnovation #Pharma #Trending #Medtech #PharmaServices #BioTech #GlobalSupplyChain #HealthTechMarket

Pharma outsourcing isn’t just about clinical trials and drug manufacture. The big pharma companies are increasingly relying on outsourced partners for commercialization too, in areas such as digital, rare disease, and reimbursement. Download this report to learn more.

We are not surprised that after pandemic we see a huge increase in investment in life sciences, research and pharmaceuticals production. But when we go to pharmacy to buy a necessary medicines we normally do not think how it is produced, what technology is behind it. Check Arnaud Cantin's recent blog on how power digitalization can revolutionize the world of life sciences! Increasing product complexity and rising demand to growing regulatory pressures reliable power distribution is one of the key things to address these challenges. http://spr.ly/6040XQjFw

As an innovation catalyst, we're here to help ensure that no technology lags behind ⚙    Here are 4 high-potential sectors that are shaping up for dynamic innovation in 2024 ⬇    To learn more, read this blog by our Chief Strategy Officer, Arun Harish ➡ https://lnkd.in/eAVa2xYP    #EVs | #Oligos | #Pharma  #LetsInnovateTogether | #Innovation | #DeepTech 

Have you ever wondered where the #Medicine you take is coming from? 💊❓ It is likely that its roots lie in the Medicines Manufacturing Innovation Centre - a collaboration of many #Pharma manufacturers led by CPI. At the innovation center, specialists formulate, test and roll out the next big thing for pharma companies. As a #DigitalEnterprise, the center makes use of big data to fine-tune processes, accelerate development times, and reduce energy, waste, and cost. Read on ➡ https://sie.ag/6BSxVq

The key conundrum facing the pharma space is how to balance exciting innovation with an ever-spiralling cost crisis 🧪🩺 From outsourcing to specialization, read more on the top trends shaping the future of pharma in Advent's guide: https://lnkd.in/eH_W3x2h

The North: The place to be for pharma manufacturing? At the Bionow pharma manufacturing conference, our Technical Director and #NorthernPowerhouseInvestmentChampion Adeel Aslam joined a panel to discuss why the North of England is the place to be for pharma manufacturing. Key insights include: • The North’s rich history and bright future in life sciences. • The ongoing investments positioning the North as a global leader. • Collaboration among industry leaders is key! To learn more about how the North is shaping the future of #pharmamanufacturing, read the article here: https://bit.ly/4cSk1BO #InvestInTheNorth #Bionow

Our latest paper reveals the trends shaping the evolution of Pharma Services M&A, reflecting on the challenges of 2023 while forecasting the changes ahead. Read the latest paper here: https://okt.to/JAKopP Authors: Al-Munther Sultan, Claire Edwards, Lara Tentori #Amon #PharmaServices #MA

Significant room for improvement: Over the past two decades, new molecular entity launches underperformed at a rate of around $200 million per asset versus market expectations. Here is one major contributor to underperformance and how pharma companies can improve their R&D productivity in the future: